HBM Healthcare Investments reports a compelling 15 percent increase in NAV in the 2024 calendar year
Werte in diesem Artikel
HBM Healthcare Investments AG / Key word(s): Quarter Results Werbung Werbung HBM Healthcare Investments closed the calendar year 2024 with a strong performance. Its net asset value (NAV) per share rose by 15 percent to CHF 251.17. By contrast, the share price failed to reflect this good performance, growing only marginally by 0.5 percent to CHF 176.00. The market capitalisation is thus almost 30 percent or more than CHF 500 million below the NAV, which corresponds to practically the entire book value of the portfolio of private companies and thus takes into account neither its value nor its potential for added value. In addition to listed companies, private companies made a significant contribution to performance (Johnson & Johnson's acquisition of Yellow Jersey Therapeutics and the IPO of Sai Life Sciences in India). In addition, most investment currencies appreciated against the Swiss franc, contributing 6.8%. Werbung Werbung The relevant healthcare sector market indices, measured in Swiss francs, also performed positively, but all lagged behind HBM Healthcare Investments (MSCI World Health Care Index +9.9%, Nasdaq Biotechnology Index (NBI) +7.6% and SPDR S&P Biotech (XBI) +9.3%). Positive results also in the first nine months of the 2024/2025 financial year Werbung Werbung The NAV rose by 4.3 percent in the first nine months of the 2024/2025 financial year, resulting in a net profit of around CHF 66 million (previous year: net loss of CHF 157.5 million). Performance during the period was mainly driven by the aforementioned private companies, while the listed companies were slightly negative. Foreign currencies had no significant impact. The figures presented here are provisional based on the current status of the work on the financial statements. The final result will be published in the quarterly report on 20 January 2025. Contact End of Inside Information |
Language: | English |
Company: | HBM Healthcare Investments AG |
Bundesplatz 1 | |
6300 Zug | |
Switzerland | |
Phone: | +41438887171 |
Fax: | +41438887172 |
E-mail: | info@hbmhealthcare.com |
Internet: | https://www.hbmhealthcare.com |
ISIN: | CH0012627250 |
Valor: | 1262725 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2061425 |
End of Announcement | EQS News Service |
|
2061425 03-Jan-2025 CET/CEST
Ausgewählte Hebelprodukte auf HBM Healthcare Investments
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf HBM Healthcare Investments
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu HBM Healthcare Investments AG
Analysen zu HBM Healthcare Investments AG
Keine Analysen gefunden.